Germany's BioNTech to buy CureVac to boost cancer research

Updated on: July 08,2025 0

Germany's BioNTech to buy CureVac to boost cancer research

Updated on:July 08,2025 0

Combination therapy found safe and beneficial for acute myeloid leukemia patients with specific genetic profile

Updated on: July 14,2025 0

Combination therapy found safe and beneficial for acute myeloid leukemia patients with specific genetic profile

Updated on:July 14,2025 0

Study shows the glucocorticoid receptor is a double-edged sword in prostate cancer

Updated on: July 14,2025 0

Study shows the glucocorticoid receptor is a double-edged sword in prostate cancer

Updated on:July 14,2025 0

Enzyme inhibitor strategy converts neuroblastoma cells into healthy neurons in mice

Updated on: July 10,2025 0

Enzyme inhibitor strategy converts neuroblastoma cells into healthy neurons in mice

Updated on:July 10,2025 0

Novel assay promises more efficient screening for carriers of fragile X syndrome

Updated on: July 10,2025 0

Novel assay promises more efficient screening for carriers of fragile X syndrome

Updated on:July 10,2025 0

Weekly Update of Drug News-19/8/2025

Updated on: August 19,2025 0

Weekly Update of Drug News-19/8/2025

Updated on:August 19,2025 0

A new AI algorithm is working to get chemotherapy dosing right

Updated on: July 13,2025 0

A new AI algorithm is working to get chemotherapy dosing right

Updated on:July 13,2025 0

SGLT2 inhibitor treatment stabilizes kidney function in patients who have had a heart attack

Updated on: July 09,2025 0

SGLT2 inhibitor treatment stabilizes kidney function in patients who have had a heart attack

Updated on:July 09,2025 0

Unexpected role for testis protein: BRDT implicated as lung cancer driver

Updated on: May 19,2025 0

Unexpected role for testis protein: BRDT implicated as lung cancer driver

Updated on:May 19,2025 0

Some lung cancer patients may experience durable disease control even after discontinuing immunotherapy

Updated on: May 19,2025 0

Some lung cancer patients may experience durable disease control even after discontinuing immunotherapy

Updated on:May 19,2025 0